[Clinical study of Wenxikeli treatment of viral myocarditis].
To observe Wenxinkeli viral myocarditis clinical efficacy and safety. 45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks. The treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05). Wenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.